601607 上海醫藥
按盤價 
17.790 +0.310 (+1.773%) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 5.558 | 9.650 | 10.755 | 10.335 | 10.117 |
| 總資產報酬率 ROA (%) | 1.838 | 3.107 | 3.259 | 3.142 | 3.093 |
| 投入資產回報率 ROIC (%) | 3.146 | 5.510 | 5.870 | 5.317 | 5.028 | 邊際利潤分析 |
| 銷售毛利率 (%) | 12.036 | 13.142 | 13.225 | 13.928 | 14.372 |
| 營業利潤率 (%) | 2.946 | 3.886 | 3.802 | 3.744 | 3.331 |
| 息稅前利潤/營業總收入 (%) | 3.281 | 4.363 | 4.350 | 4.385 | 4.031 |
| 淨利潤/營業總收入 (%) | 1.985 | 3.014 | 2.907 | 2.921 | 2.589 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 103.288 | 80.311 | 75.920 | 88.486 | 98.265 |
| 價值變動淨收益/利潤總額(%) | 4.772 | 8.536 | 19.713 | 15.232 | 12.390 |
| 營業外收支淨額/利潤總額(%) | -8.689 | -2.342 | -0.757 | -0.124 | 0.775 | 償債能力分析 |
| 流動比率 (X) | 1.327 | 1.351 | 1.269 | 1.220 | 1.315 |
| 速動比率 (X) | 1.028 | 1.039 | 0.973 | 0.947 | 0.981 |
| 資產負債率 (%) | 62.105 | 60.632 | 63.860 | 63.307 | 63.959 |
| 帶息債務/全部投入資本 (%) | 42.103 | 39.011 | 38.299 | 40.469 | 45.977 |
| 股東權益/帶息債務 (%) | 130.853 | 149.257 | 145.253 | 132.160 | 107.446 |
| 股東權益/負債合計 (%) | 52.052 | 55.824 | 47.293 | 48.022 | 47.534 |
| 利息保障倍數 (X) | 5.748 | 7.708 | 7.539 | 6.789 | 5.975 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 96.601 | 96.888 | 92.453 | 93.875 | 86.342 |
| 存貨周轉天數 (天) | 55.882 | 54.997 | 49.202 | 53.359 | 56.226 |
| 備註： | 即時報價更新時間為 19/04/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
